Table of Contents
Recent Monoclonal Antibody Trials in the Management of Coronary Artery Disease
RB Singh, Krasimira Hristova, Jan Fedacko, Rajeev Gupta, and Hilton Chaves
Can Halberg’s Chronotherapy Approach Increase Efficacy and Safety of PCSK9 Inhibitors and Decrease Their Adverse Effects?
RB Singh, Germaine Cornelissen, Anna Gvozdjáková, Jan Fedacko, Banshi Saboo, and Anuj Maheshwari
Study Protocol for a New Study. Can Chronotherapy Enhance Efficacy and Diminish Adverse Effects of PCSK9 Inhibitors in the Management of Acute Coronary Syndromes?
Jan Fedacko, Krasimira Hristova, Galal Elkilany, JP Sharma, Germaine Cornelissen, RB Singh, Banshi Saboo, and Ramesh K. Goyal
The Challenges of New Guidelines for Management of Hypertension: A View Point of the International College of Cardiology
Krassimira Hristova, RB Singh, Germaine Cornelissen, Jan Fedacko, Daniel Pella, Hilton Chaves, Galal Elkilany, and Kuniaki Otsuka
New Coronary Risk Factors in Chronic Heart Failure
RB Singh, Adarsh Kumar, Krasimira Hristova, Jan Fedacko, Shantanu Singhal, Douglas W Wilson, and Toru Takahashi
Mitochondrial Coenzyme Q and Oxidative Phosphorylation in Brain and Myocardium of Control and Diabetic Rats
Anna Gvozdjáková, Jarmila Kucharská, Oľga Vančová, Oľga Uličná, Viliam Mojto, RB Singh, and Germaine Cornelissen
Effect of Maternal Dietary Supplementation on Complications of Pregnancy and Infancy and Metabolic Syndrome in Later Adult Life
Poonam Singh, Rajesh K Singh, RB Singh, Banshi Saboo, Galal Elkilany, Krasimira Hristova, DW Wilson, and Fabien De Meester
Can Brain-Derived Neurotrophic Factor Modulate Cardiometabolic Risk for Prevention of Vascular Disease?
RB Singh, Anuj Maheshwari, Toru Takahashi, Miki Tokunaga, Agnieszka Wilczynska, Banshi Saboo, Fabien De Meester, Galal Elkilany, Krasimira Hristova, Douglas W Wilson, and Sergey Shastun
Brain Stress Is a Risk Factor for Heart Attack, High Blood Pressure, and Diabetes
Tatjana Gligorijevic, Brainislav Milovanomic, and RB Singh